Aarvik Therapeutics

Developer of antibody-drug conjugates for oncology targets

placeHayward, California, United States calendar_todayFounded 2021 groups9 employees language aarviktx.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 36 times.

YearFilings
20231
20253

Social engagement

Social engagement: 2.1K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon